BRAF and melanoma: Among the BRAF mutations identified thus far, BRAFV600E is most common with frequencies ~50% in melanomas, ~40% of papillary thyroid carcinomas, ~10% of colorectal cancers, ~5% of lung adenocarcinomas while also being detected in a subset of brain and hematological malignancies (Table 1).